Login / Signup
Birgitta Leuthner
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
2025
2016
Top Topics
2025
2016
Genome Editing
2025
2016
Poor Prognosis
2025
2016
High Glucose
2025
2016
Renal Cell Carcinoma
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Manja Friese-Hamim
,
Maria J Ortiz-Ruiz
,
Olga Bogatyrova
,
Marina Keil
,
Felix Rohdich
,
Beatrix Blume
,
Birgitta Leuthner
,
Frank Czauderna
,
Diane Hahn
,
Julia Jabs
,
Frank Jaehrling
,
Timo Heinrich
,
Roland Kellner
,
Katherine Chan
,
Amy H Y Tong
,
Dirk Wienke
,
Jason Moffat
,
Andree Blaukat
,
Frank T Zenke
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.
Molecular cancer therapeutics
(2023)